KestonA.S., BallR.P., FrantzV.K., PalmerW.W.. Storage of radioactive iodine in a metastasis from thyroid carcinoma.Science1942; 95: 362–3
2.
CassenB., CurtisL., ReedC., LibbyR.. Instrumentation for 131I use in medical studies.Nucleonics1951; 9: 46–50
3.
BaumanE.J., SearleN., YallowA.A., SiegelE., SeidlinS.M.. Filtration of seventh group elements by the thyroid, studied with radioactive isotopes (abstract).International Physiologic Congress1953; 19: 194–5
4.
HarperP.V., BeckR., CharlestonD., LathropK.A.. Optimization of a scanning method using 99mTc.Nucleonics1964; 22: 50–4
5.
GooldenA.W.G., GlassH.I., SilvesterD.J.. The choice of a radioactive isotope for the investigation of thyroid disorders.Br J Radiol1968; 41: 20–5
6.
PerlmutterM., SlaterS.L.. Which nodular goitres should be removed?N Engl J Med1956; 255: 65–71
7.
MaiseyM.N.. Methods of investigation in the diagnosis and management of thyroid carcinoma.World J Surg1981; 5: 49–59.
8.
KarelitzJ.R., RichardsJ.B.. Necessity of oblique views in evaluating the functional status of a thyroid nodule.J Nucl Med Allied Sci1975; 15: 782–5
9.
RyoU.Y., ArnoldJ., ColmanM.Thyroid scintigram. Sensitivity with sodium pertechnetate 99mTc and gamma camera with pinhole collimator.JAMA1976; 235: 1235–8
10.
LaheyF.H.. Preoperative diagnosis of carcinoma of the thyroid in surgery of the thyroid.Surg Clin North Am1953; 33: 781–92
11.
KusicZ., RatcliffeG.E., MaiseyM.N., SaundersA.J.S.. An assessment of the potential role of routine radionuclide thyroid scanning in the differentiation between solid and cystic lesions in the solitary thyroid nodule.Eur J Nucl Med1983; 8: 321–4
12.
MassinJ.P., PlauchonC., PerezR.. Comparison of 99mTc-pertechnetate and 131I scanning of thyroid nodules.Clin Nucl Med1977; 2: 324–33
13.
KaplanW.D., HolmanB.L., SelenkowH.A.67Gacitrate and the non-functioning thyroid nodule.J Nucl Med Allied Sci1974; 15: 424–7
14.
MoriT., HamamotoK., OnayamaY., TorizukaK.. Tumour imaging after administration of 99mTc labelled bleomycin.J Nucl Med1975; 16: 414–22
15.
AckermanN.B., ShahonD.B., MarvinJ.F.. The diagnosis of thyroid cancer with radioactive phosphorus.Surgery1960; 47: 615–22
16.
MurrayI.P.C., StewartR.D.H., IndykJ.S.. Thyroid scanning with 131Cs.Br Med J1970; 4: 653–6
17.
ThomasC.G., PepperF.D., OwenJ.. Differentiation of malignant from benign lesions of the thyroid gland using complementary scanning with 75selenomethionine and radioiodide.Ann Surg1969; 170: 396–408
18.
WeinsteinM.B., AshkarF.S., CaronC.D.. 75Se selenomethionine as a scanning agent for the differential diagnosis of the cold thyroid nodule.Semin Nucl Med1971; 1: 390–6
19.
HaradaT., ItoY., ShimaokaK., TaniguchiT., MatsudoA., SenooT.. Clinical evaluation of 201Thallium chloride scan for thyroid nodule.Eur J Nucl Med1980; 5: 125–30
20.
TennvallJ., PalmerJ., CederquistE.Scintigraphic evaluation and dynamic studies with thallium-201 in thyroid lesions with suspected cancer.Eur J Nucl Med1981; 6: 295–300
21.
SengaO., MiyakawaM., ShirotaH.Comparison of T1-201 chloride and Ga-67 citrate scintigraphy in the diagnosis of thyroid tumour: concise communication.J Nucl Med1982; 23: 225–8
22.
Ng Tang FuiS.C., HoffenbergR., BlackE.G., MaiseyM.N.. Serum thyroglobulin concentration and whole-body radioiodine scan in the follow-up of differentiated thyroid cancer after thyroid ablation.Br Med J1979; 2: 298–300
23.
ShepherdP.S., LazarusC.R., MistryR.D., MaiseyM.N.. Detection of thyroid tumour using a monoclonal 123I anti-human thyroglobulin antibody.Eur J Nucl Med1985; 10: 291–5
24.
HoefnagelC.A., DelpratC.C., MarcuseH.R., De-VijlderJ.J.. Role of thallium-201 total body scintigraphy in follow-up of thyroid carcinoma.J Nucl Med1986; 27: 1854–7
25.
AndersonR.J., SizemoreG.W., WahnerH.W., CarneyJ.A.. Thyroid scintigram in familial medullary carcinoma of the thyroid gland.Clin Nucl Med1978; 3: 147–51
26.
JohnsonD.G., ColemanR.E., McCookT.A., DaleJ.K., WellsS.A.. Bone and liver scans in medullary carcinoma of the thyroid.J Nucl Med1984; 25: 419–22
27.
ParthasarathyK.L., ShirmaokaK., BakshiS.P., RazackM.S.. Radiotracer uptake in medullary carcinoma of the thyroid.Clin Nucl Med1983; 8: 45–8
EndoK., ShiomiK., KasagiK.Imaging of medullary thyroid cancer with 131I-MIBG.Lancet1984; ii: 233
30.
OhtaH., YamamotoK., EndoK.A new imaging agent for medullary carcinoma of the thyroid.J Nucl Med1984; 25: 323–5
31.
ClarkeS.E.M., LazarusC.R., WraightP., SampsonC., MaiseyM.N.. Pentavalent 99mTc DMSA, 131I MIBG and 99mTc MDP – an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.J Nucl Med1988; 29: 33–8
32.
ShaneE., BilezikianJ.P.. Parathyroid carcinoma: A review of 62 patients.Endocr Rev1982; 3: 218–26
33.
FujimotoY., OharaT.. How to recognize and treat parathyroid carcinoma.Surg Clin North Am1987; 67: 343–57
StellP.M., MortonR.P., SinghS.D.. Cervical lymph node metastases: the significance of the level of the lymph node.Clin Oncol1983; 9: 101–7
36.
GrandiC., AlloisioM., MogliaD.Prognostic significance of lymphatic spread in head and neck carcinomas: Therapeutic implications.Head Neck Surg1985; 8: 67–73
37.
SakoK., PradierR.N., MarchettaF.C., PickrenJ.W.. Fallibility of palpation in diagnosis of metastases to nodes.Surg Gynecol Obstet1964; 118: 989–90
JohnsonG.S., LarsonA.L., McCurdyH.W.. Tumour localization in the nasopharynx using radiomercury labelled chlormerodrin.J Nucl Med1965; 6: 549–54
40.
KashimaH.K., McKusickK.A., MalmudL.S., WagnerH.N.. Gallium-67 scanning in patients with head and neck cancer.Laryngoscope1974; 84: 1078–89
41.
TeatesC.D., PrestonD.F., BoydC.M.. Gallium-67 citrate imaging in head and neck tumours: report of cooperative group.J Nucl Med1980; 21: 622–7
42.
CummingsC.W., LarsonS.M., DobieR.A., WeymullerE.A., RuddT.G., MerelloA.. Assessment of cobalt 57 tagged bleomycin as a clinical aid in staging of head and neck carcinoma.Laryngoscope1981; 91: 529–37
43.
GoodwinD.A., MearesC.F., De RiemerL.H.Clinical studies with In-III BLEDTA, a tumour-imaging conjugate of bleomycin with a bifunctional chelating agent.J Nucl Med1981; 22: 787–92
44.
LinM.S., GoodwinD.A., KruseS.L.. Bleomycin as a 99mTc carrier in tumour visualization.J Nucl Med1974; 15: 338–42
45.
GrantH., SmithN.J.. Scintillation scanning using Tc99m as a means of investigating mucosal lesions of the nose and paranasal sinuses.J Laryngol Otol1974; 88: 919–26
BlakesleeD.B., BeckerG.D., SimpsonG.T., PattenD.H., SprengelmeyerJ.. Lymphoscintigraphy of the neck.Otolaryngol Head Neck Surg1985; 93: 361–5
48.
SooK.C., WardM., RobertsK.R.Radioimmunoscintigraphy of squamous carcinomas of the head and neck.Head Neck Surg1987; 9: 349–52
49.
OhtaH., EndoK., FujitaT.Imaging of head and neck tumours with technetium (V) – 99m DMSA. A new tumour-seeking agent.Clin Nucl Med1985; 10: 855–60
50.
WatkinsonJ.C., ClarkeS.E.M., ShaheenO.H.. An evaluation of the uptake of technetium - 99m (V) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck.Clin Otolaryngol1987; 12: 405–11
51.
EdwardsC.L., HayesR.L.. Tumour scanning with 67Gacitrate.J Nucl Med1969; 10: 103–5
52.
AndrewsG.A., EdwardsC.L.. Tumour scanning with gallium 67.JAMA1975; 223: 1100–3
53.
TurnerD.A., FordhamE.W., AliA., SlaytonR.E.. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas.Semin Nucl Med1978; 8: 205–18
54.
BekermanC., HofferP.B.. Salivary gland uptake of 67Gacitrate following radiation therapy.J Nucl Med1976; 17: 685–7
55.
NoyekA.M.. Bone scanning in otolaryngology.Laryngoscope1979; 89 Supplement 18: 1–87
BuraggiG.L., CallegaroL., MarianiG.Imaging with 131I-labelled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.Cancer Res1985; 45: 3378–87
58.
KhafagiF., Egerton-VernonJ., Van DoomT., FosterW., McPheeI.B., AllisonR.W.G.. Localization and treatment of familial malignant nonfunctional paraganglioma with iodine-131 MIBG: Report of two cases.J Nucl Med1987; 28: 528–31
59.
DaviesJ.O.. Tumour imaging using monoclonal antibodies.Hosp Update1986; 12: 257–9
60.
WatkinsonJ.C.. A study of the biodistribution, pharmacokinetics and dosimetry of Tc99m (V) dimercaptosuccinic acid (pentavalent DMSA). MSc Thesis London University1987